Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin.?The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system.?Diabetes is categorized by increased levels of blood glucose, which can cause severe damage to blood vessels, heart, kidneys, nerves, and eyes.?Diabetes is also called hyperglycemia or raised blood sugar.?Insulin is a hormone that regulates the blood sugar level in body.?Continuous increase in blood sugar leads to diabetes.?Uncontrollable diabetes can damage the nervous system and other body systems.?Diabetes is of two types: type 1 and type 2.?Type 1 diabetes, also known as juvenile diabetes or insulin-dependent diabetes, arises when the immune system misguidedly attacks and kills the beta cells of the pancreas.?In type 1 diabetes, little or no insulin is released into the body, owing to this sugar builds up in the blood instead of being used as energy.?Type 1 diabetes is rare, and only 10% of people with diabetes have type 1 diabetes.?It commonly occurs in childhood or adolescence.?Type 2 diabetes arises when the body cannot appropriately use the insulin that is released or does not make enough insulin.?As a consequence, sugar builds up in the blood instead of being used as energy.?About 90% of people with diabetes have type 2 diabetes.
This report aims to provide a comprehensive presentation of the global market for Oral Anti-diabetes Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anti-diabetes Drugs. This report contains market size and forecasts of Oral Anti-diabetes Drugs in global, including the following market information:
Global Oral Anti-diabetes Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Oral Anti-diabetes Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
by Type Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral Anti-diabetes Drugs include Sanofi, Eli Lilly, AstraZeneca plc, Astellas Pharma Inc, Johnson & Johnson (Janssen Pharmaceuticals), Boehringer Ingelheim, Merck, Takeda and Bristol Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Anti-diabetes Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Anti-diabetes Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Oral Anti-diabetes Drugs Market Segment Percentages, by Type, 2022 (%)
by Type
Liquid
Capsule
Tablet
by Drug Class
Sulfonylureas
Meglitinides
Biguanides
Others
Global Oral Anti-diabetes Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Oral Anti-diabetes Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Oral Anti-diabetes Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Oral Anti-diabetes Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Anti-diabetes Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oral Anti-diabetes Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy?s Laboratories Ltd
Glenmark Pharmaceuticals Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Anti-diabetes Drugs, market overview.
Chapter 2: Global Oral Anti-diabetes Drugs market size in revenue.
Chapter 3: Detailed analysis of Oral Anti-diabetes Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Anti-diabetes Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Anti-diabetes Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Anti-diabetes Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Anti-diabetes Drugs Overall Market Size
2.1 Global Oral Anti-diabetes Drugs Market Size: 2022 VS 2032
2.2 Global Oral Anti-diabetes Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oral Anti-diabetes Drugs Players in Global Market
3.2 Top Global Oral Anti-diabetes Drugs Companies Ranked by Revenue
3.3 Global Oral Anti-diabetes Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oral Anti-diabetes Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oral Anti-diabetes Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Anti-diabetes Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oral Anti-diabetes Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oral Anti-diabetes Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Anti-diabetes Drugs Market Size Markets, 2022 & 2032
4.1.2 Liquid
4.1.3 Capsule
4.1.4 Tablet
4.2 By Type - Global Oral Anti-diabetes Drugs Revenue & Forecasts
4.2.1 By Type - Global Oral Anti-diabetes Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oral Anti-diabetes Drugs Revenue, 2024-2032
4.2.3 By Type - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Anti-diabetes Drugs Market Size, 2022 & 2032
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Oral Anti-diabetes Drugs Revenue & Forecasts
5.2.1 By Application - Global Oral Anti-diabetes Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oral Anti-diabetes Drugs Revenue, 2024-2032
5.2.3 By Application - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Oral Anti-diabetes Drugs Market Size, 2022 & 2032
6.2 By Region - Global Oral Anti-diabetes Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Anti-diabetes Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oral Anti-diabetes Drugs Revenue, 2024-2032
6.2.3 By Region - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Oral Anti-diabetes Drugs Revenue, 2018-2032
6.3.2 US Oral Anti-diabetes Drugs Market Size, 2018-2032
6.3.3 Canada Oral Anti-diabetes Drugs Market Size, 2018-2032
6.3.4 Mexico Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Oral Anti-diabetes Drugs Revenue, 2018-2032
6.4.2 Germany Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.3 France Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.4 U.K. Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.5 Italy Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.6 Russia Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Oral Anti-diabetes Drugs Market Size, 2018-2032
6.4.8 Benelux Oral Anti-diabetes Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Oral Anti-diabetes Drugs Revenue, 2018-2032
6.5.2 China Oral Anti-diabetes Drugs Market Size, 2018-2032
6.5.3 Japan Oral Anti-diabetes Drugs Market Size, 2018-2032
6.5.4 South Korea Oral Anti-diabetes Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Oral Anti-diabetes Drugs Market Size, 2018-2032
6.5.6 India Oral Anti-diabetes Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Oral Anti-diabetes Drugs Revenue, 2018-2032
6.6.2 Brazil Oral Anti-diabetes Drugs Market Size, 2018-2032
6.6.3 Argentina Oral Anti-diabetes Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, 2018-2032
6.7.2 Turkey Oral Anti-diabetes Drugs Market Size, 2018-2032
6.7.3 Israel Oral Anti-diabetes Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Oral Anti-diabetes Drugs Market Size, 2018-2032
6.7.5 UAE Oral Anti-diabetes Drugs Market Size, 2018-2032
7 Oral Anti-diabetes Drugs Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Oral Anti-diabetes Drugs Major Product Offerings
7.1.4 Sanofi Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Oral Anti-diabetes Drugs Major Product Offerings
7.2.4 Eli Lilly Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Company Summary
7.3.2 AstraZeneca plc Business Overview
7.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Major Product Offerings
7.3.4 AstraZeneca plc Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca plc Key News & Latest Developments
7.4 Astellas Pharma Inc
7.4.1 Astellas Pharma Inc Company Summary
7.4.2 Astellas Pharma Inc Business Overview
7.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Major Product Offerings
7.4.4 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.4.5 Astellas Pharma Inc Key News & Latest Developments
7.5 Johnson & Johnson (Janssen Pharmaceuticals)
7.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Company Summary
7.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Business Overview
7.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Major Product Offerings
7.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Major Product Offerings
7.6.4 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Oral Anti-diabetes Drugs Major Product Offerings
7.7.4 Merck Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Takeda
7.8.1 Takeda Company Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Oral Anti-diabetes Drugs Major Product Offerings
7.8.4 Takeda Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.8.5 Takeda Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Major Product Offerings
7.9.4 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Oral Anti-diabetes Drugs Major Product Offerings
7.10.4 Novartis Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Oral Anti-diabetes Drugs Major Product Offerings
7.11.4 Pfizer Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
7.12 Abbott
7.12.1 Abbott Company Summary
7.12.2 Abbott Business Overview
7.12.3 Abbott Oral Anti-diabetes Drugs Major Product Offerings
7.12.4 Abbott Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.12.5 Abbott Key News & Latest Developments
7.13 Biocon
7.13.1 Biocon Company Summary
7.13.2 Biocon Business Overview
7.13.3 Biocon Oral Anti-diabetes Drugs Major Product Offerings
7.13.4 Biocon Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.13.5 Biocon Key News & Latest Developments
7.14 Sunpharma
7.14.1 Sunpharma Company Summary
7.14.2 Sunpharma Business Overview
7.14.3 Sunpharma Oral Anti-diabetes Drugs Major Product Offerings
7.14.4 Sunpharma Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.14.5 Sunpharma Key News & Latest Developments
7.15 Novo Nordisk
7.15.1 Novo Nordisk Company Summary
7.15.2 Novo Nordisk Business Overview
7.15.3 Novo Nordisk Oral Anti-diabetes Drugs Major Product Offerings
7.15.4 Novo Nordisk Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.15.5 Novo Nordisk Key News & Latest Developments
7.16 Piramal Healthcare
7.16.1 Piramal Healthcare Company Summary
7.16.2 Piramal Healthcare Business Overview
7.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Major Product Offerings
7.16.4 Piramal Healthcare Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.16.5 Piramal Healthcare Key News & Latest Developments
7.17 Bayer Healthcare
7.17.1 Bayer Healthcare Company Summary
7.17.2 Bayer Healthcare Business Overview
7.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Major Product Offerings
7.17.4 Bayer Healthcare Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.17.5 Bayer Healthcare Key News & Latest Developments
7.18 Dr. Reddy?s Laboratories Ltd
7.18.1 Dr. Reddy?s Laboratories Ltd Company Summary
7.18.2 Dr. Reddy?s Laboratories Ltd Business Overview
7.18.3 Dr. Reddy?s Laboratories Ltd Oral Anti-diabetes Drugs Major Product Offerings
7.18.4 Dr. Reddy?s Laboratories Ltd Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.18.5 Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
7.19 Glenmark Pharmaceuticals Ltd
7.19.1 Glenmark Pharmaceuticals Ltd Company Summary
7.19.2 Glenmark Pharmaceuticals Ltd Business Overview
7.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Major Product Offerings
7.19.4 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue in Global Market (2018-2023)
7.19.5 Glenmark Pharmaceuticals Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oral Anti-diabetes Drugs Market Opportunities & Trends in Global Market
Table 2. Oral Anti-diabetes Drugs Market Drivers in Global Market
Table 3. Oral Anti-diabetes Drugs Market Restraints in Global Market
Table 4. Key Players of Oral Anti-diabetes Drugs in Global Market
Table 5. Top Oral Anti-diabetes Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oral Anti-diabetes Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oral Anti-diabetes Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oral Anti-diabetes Drugs Product Type
Table 9. List of Global Tier 1 Oral Anti-diabetes Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Anti-diabetes Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oral Anti-diabetes Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Oral Anti-diabetes Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oral Anti-diabetes Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Sanofi Company Summary
Table 31. Sanofi Oral Anti-diabetes Drugs Product Offerings
Table 32. Sanofi Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Oral Anti-diabetes Drugs Product Offerings
Table 36. Eli Lilly Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. AstraZeneca plc Company Summary
Table 39. AstraZeneca plc Oral Anti-diabetes Drugs Product Offerings
Table 40. AstraZeneca plc Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca plc Key News & Latest Developments
Table 42. Astellas Pharma Inc Company Summary
Table 43. Astellas Pharma Inc Oral Anti-diabetes Drugs Product Offerings
Table 44. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Astellas Pharma Inc Key News & Latest Developments
Table 46. Johnson & Johnson (Janssen Pharmaceuticals) Company Summary
Table 47. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product Offerings
Table 48. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson (Janssen Pharmaceuticals) Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Oral Anti-diabetes Drugs Product Offerings
Table 52. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Oral Anti-diabetes Drugs Product Offerings
Table 56. Merck Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Takeda Company Summary
Table 59. Takeda Oral Anti-diabetes Drugs Product Offerings
Table 60. Takeda Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Takeda Key News & Latest Developments
Table 62. Bristol Myers Squibb Company Summary
Table 63. Bristol Myers Squibb Oral Anti-diabetes Drugs Product Offerings
Table 64. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Oral Anti-diabetes Drugs Product Offerings
Table 68. Novartis Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Oral Anti-diabetes Drugs Product Offerings
Table 72. Pfizer Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Abbott Company Summary
Table 75. Abbott Oral Anti-diabetes Drugs Product Offerings
Table 76. Abbott Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Abbott Key News & Latest Developments
Table 78. Biocon Company Summary
Table 79. Biocon Oral Anti-diabetes Drugs Product Offerings
Table 80. Biocon Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Biocon Key News & Latest Developments
Table 82. Sunpharma Company Summary
Table 83. Sunpharma Oral Anti-diabetes Drugs Product Offerings
Table 84. Sunpharma Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Sunpharma Key News & Latest Developments
Table 86. Novo Nordisk Company Summary
Table 87. Novo Nordisk Oral Anti-diabetes Drugs Product Offerings
Table 88. Novo Nordisk Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Novo Nordisk Key News & Latest Developments
Table 90. Piramal Healthcare Company Summary
Table 91. Piramal Healthcare Oral Anti-diabetes Drugs Product Offerings
Table 92. Piramal Healthcare Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Piramal Healthcare Key News & Latest Developments
Table 94. Bayer Healthcare Company Summary
Table 95. Bayer Healthcare Oral Anti-diabetes Drugs Product Offerings
Table 96. Bayer Healthcare Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Bayer Healthcare Key News & Latest Developments
Table 98. Dr. Reddy?s Laboratories Ltd Company Summary
Table 99. Dr. Reddy?s Laboratories Ltd Oral Anti-diabetes Drugs Product Offerings
Table 100. Dr. Reddy?s Laboratories Ltd Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Dr. Reddy?s Laboratories Ltd Key News & Latest Developments
Table 102. Glenmark Pharmaceuticals Ltd Company Summary
Table 103. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product Offerings
Table 104. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Glenmark Pharmaceuticals Ltd Key News & Latest Developments
List of Figures
Figure 1. Oral Anti-diabetes Drugs Segment by Type in 2022
Figure 2. Oral Anti-diabetes Drugs Segment by Application in 2022
Figure 3. Global Oral Anti-diabetes Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oral Anti-diabetes Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Oral Anti-diabetes Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Anti-diabetes Drugs Revenue in 2022
Figure 8. By Type - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 16. US Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 28. China Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Oral Anti-diabetes Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Oral Anti-diabetes Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Sanofi Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca plc Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Takeda Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Abbott Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Biocon Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Sunpharma Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Novo Nordisk Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Piramal Healthcare Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Bayer Healthcare Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Dr. Reddy?s Laboratories Ltd Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
